154 related articles for article (PubMed ID: 10545320)
1. The Ig fold of the core binding factor alpha Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains.
Berardi MJ; Sun C; Zehr M; Abildgaard F; Peng J; Speck NA; Bushweller JH
Structure; 1999 Oct; 7(10):1247-56. PubMed ID: 10545320
[TBL] [Abstract][Full Text] [Related]
2. The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.
Bäckström S; Wolf-Watz M; Grundström C; Härd T; Grundström T; Sauer UH
J Mol Biol; 2002 Sep; 322(2):259-72. PubMed ID: 12217689
[TBL] [Abstract][Full Text] [Related]
3. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
Nagata T; Werner MH
J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
[TBL] [Abstract][Full Text] [Related]
4. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.
Tahirov TH; Inoue-Bungo T; Morii H; Fujikawa A; Sasaki M; Kimura K; Shiina M; Sato K; Kumasaka T; Yamamoto M; Ishii S; Ogata K
Cell; 2001 Mar; 104(5):755-67. PubMed ID: 11257229
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain.
Nagata T; Gupta V; Sorce D; Kim WY; Sali A; Chait BT; Shigesada K; Ito Y; Werner MH
Nat Struct Biol; 1999 Jul; 6(7):615-9. PubMed ID: 10404214
[TBL] [Abstract][Full Text] [Related]
6. Energetic contribution of residues in the Runx1 Runt domain to DNA binding.
Li Z; Yan J; Matheny CJ; Corpora T; Bravo J; Warren AJ; Bushweller JH; Speck NA
J Biol Chem; 2003 Aug; 278(35):33088-96. PubMed ID: 12807882
[TBL] [Abstract][Full Text] [Related]
7. Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit.
Zhang L; Li Z; Yan J; Pradhan P; Corpora T; Cheney MD; Bravo J; Warren AJ; Bushweller JH; Speck NA
J Biol Chem; 2003 Aug; 278(35):33097-104. PubMed ID: 12807883
[TBL] [Abstract][Full Text] [Related]
8. Solution properties of the free and DNA-bound Runt domain of AML1.
Wolf-Watz M; Xie XQ; Holm M; Grundström T; Härd T
Eur J Biochem; 1999 Apr; 261(1):251-60. PubMed ID: 10103057
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and biophysical properties of the core-binding factor alpha2 (AML1) DNA-binding domain.
Crute BE; Lewis AF; Wu Z; Bushweller JH; Speck NA
J Biol Chem; 1996 Oct; 271(42):26251-60. PubMed ID: 8824275
[TBL] [Abstract][Full Text] [Related]
10. Identification of the regions involved in DNA binding by the mouse PEBP2alpha protein.
Pérez-Alvarado GC; Munnerlyn A; Dyson HJ; Grosschedl R; Wright PE
FEBS Lett; 2000 Mar; 470(2):125-30. PubMed ID: 10734220
[TBL] [Abstract][Full Text] [Related]
11. DNA-binding by Ig-fold proteins.
Rudolph MJ; Gergen JP
Nat Struct Biol; 2001 May; 8(5):384-6. PubMed ID: 11323707
[No Abstract] [Full Text] [Related]
12. CBF--a biophysical perspective.
Bushweller JH
Semin Cell Dev Biol; 2000 Oct; 11(5):377-82. PubMed ID: 11105902
[TBL] [Abstract][Full Text] [Related]
13. CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium.
Yan J; Liu Y; Lukasik SM; Speck NA; Bushweller JH
Nat Struct Mol Biol; 2004 Sep; 11(9):901-6. PubMed ID: 15322525
[TBL] [Abstract][Full Text] [Related]
14. The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.
Bravo J; Li Z; Speck NA; Warren AJ
Nat Struct Biol; 2001 Apr; 8(4):371-8. PubMed ID: 11276260
[TBL] [Abstract][Full Text] [Related]
15. Characterization of critical interactions between Ndt80 and MSE DNA defining a novel family of Ig-fold transcription factors.
Fingerman IM; Sutphen K; Montano SP; Georgiadis MM; Vershon AK
Nucleic Acids Res; 2004; 32(9):2947-56. PubMed ID: 15161958
[TBL] [Abstract][Full Text] [Related]
16. Chloride binding by the AML1/Runx1 transcription factor studied by NMR.
Wolf-Watz M; Bäckström S; Grundström T; Sauer U; Härd T
FEBS Lett; 2001 Jan; 488(1-2):81-4. PubMed ID: 11163800
[TBL] [Abstract][Full Text] [Related]
17. Biophysical characterization of interactions between the core binding factor alpha and beta subunits and DNA.
Tang YY; Crute BE; Kelley JJ; Huang X; Yan J; Shi J; Hartman KL; Laue TM; Speck NA; Bushweller JH
FEBS Lett; 2000 Mar; 470(2):167-72. PubMed ID: 10734228
[TBL] [Abstract][Full Text] [Related]
18. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
[TBL] [Abstract][Full Text] [Related]
19. Structure and backbone dynamics of Apo-CBFbeta in solution.
Wolf-Watz M; Grundström T; Härd T
Biochemistry; 2001 Sep; 40(38):11423-32. PubMed ID: 11560490
[TBL] [Abstract][Full Text] [Related]
20. Crystallization and preliminary studies of the DNA-binding runt domain of AML1.
Bäckström S; Huang SH; Wolf-Watz M; Xie XQ; Härd T; Grundström T; Sauer UH
Acta Crystallogr D Biol Crystallogr; 2001 Feb; 57(Pt 2):269-71. PubMed ID: 11173476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
